How many drugs treat Patent ductus arteriosus?

Drug Landscape tracks 3 marketed treatments for Patent ductus arteriosus (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/patent-ductus-arteriosus.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Patent ductus arteriosus — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Patent ductus arteriosus (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Patent ductus arteriosus, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Advil	ibuprofen	Generic (originally Boots Group)	Nonsteroidal Anti-inflammatory Drug [EPC]	Sodium-coupled monocarboxylate transporter 1, Acid-sensing ion channel 1, Aldo-keto reductase family 1 member C2	1969-01-15
Indom	Indom	University of Trieste		Aldo-keto reductase family 1 member C4, Dehydrogenase/reductase SDR family member 9, Nicotinate phosphoribosyltransferase
indometacin	indometacin	Maastricht University Medical Center		Aldo-keto reductase family 1 member C4, Dehydrogenase/reductase SDR family member 9, Nicotinate phosphoribosyltransferase

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 1 drug in Patent ductus arteriosus
Generic (originally Boots Group) · 1 drug in Patent ductus arteriosus
Maastricht University Medical Center · 1 drug in Patent ductus arteriosus
University of Trieste · 1 drug in Patent ductus arteriosus

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Patent ductus arteriosus:

Cite this brief

Drug Landscape (2026). Patent ductus arteriosus — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/patent-ductus-arteriosus. Accessed 2026-06-10.

Patent ductus arteriosus full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing